APIDRA sol inj flac 10 ml

7680570130043 CH-57013 A10AB06 07.06.1.
APIDRA sol inj flac 10 ml
APIDRA sol inj flac 10 ml
APIDRA sol inj flac 10 ml
1 / 3
google

Details

Product number
5701301
CPT
-
Packaging group
1 x 10
Unit
ml
Composition
insulinum glulisinum 3.49 mg corresp. insulinum glulisinum 100 U., metacresolum, trometamolum, natrii chloridum, polysorbatum 20, acidum hydrochloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 1.97 mg.

Articles (1)

Apidra, solution injectable
Injektionslösung
1 x 10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/06/2024
Patient information leaflet
Français
18/06/2024
Patient information leaflet
Italien
18/06/2024
Professional SmPC
Allemand
18/06/2024
Professional SmPC
Français
18/06/2024
Professional SmPC
Italien
18/06/2024

Detailed composition

Substance Quantity Type Category
(N/A)
3.49 MG Substance Wirkstoff (Principe actif)
(N/A)
100.0 U Substance WIIS
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.97 MG Substance HBESI

Reimbursement information

Public price
CHF 41.00
Specialties list
Yes
Generic
No
SL addition date: 01/09/2005

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
57013
Drug name
Apidra, solution injectable
Galenic form
LSPA
ATC Code
A10AB06
Authorization status
Z
Dispensation category
B
First authorization
02/05/2005
Authorization expiration date
31/12/9999
IT number
07.06.1.
Domain
Human medicine
Field of application
Diabetes mellitus bei Erwachsenen

Packaging details

Description (FR)
APIDRA sol inj flac 10 ml
Description (DE)
APIDRA Inj Lös Durchstf 10 ml
Market launch
02/05/2005
Narcotic (BTM)
No

Other packaging sizes

APIDRA sol inj AllStar Pro/JuniorStar 5 x 3 ml
5 x 3 ML
View